# Top 5 Biotechnology Startup Investors in Isle of Man in June 2026

## Andrew Banks
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed
- Focus: Biopharma, Biotechnology, Pharmaceutical

Andrew Banks - Chairman and Co-Founder @ ABRY Partners

## Jim Mellon
- Type: Angel
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Biotechnology, Food and Beverage, Health Care

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

## Foresite Capital
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series B, Series C, Series A
- Focus: Biotechnology, Health Care, Therapeutics

We are a multi-stage investment firm, investing in companies that leverage biology and big data to transform healthcare.

## Juvenescence
- Type: VC Fund
- Location: Douglas, NA - Isle of Man, Isle of Man
- Relevant deals: 1
- Stages: Series A, Debt Financing
- Focus: Biotechnology, Pharmaceutical, Health Care

We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.

## Greg Bailey
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Series A, Post-IPO Equity, Seed
- Focus: Biotechnology, Pharmaceutical, Health Care

Dr. Gregory H. Bailey is a Managing Partner at Palantir Group, Inc. Dr. Bailey is the Co-founder of Ascent Healthcare Solutions; VirnetX Inc. (AMEX:VHC) and Duramedic Inc. He was also the initial public financier and an independent director of Medivation, Inc. (NASDAQ:MDVN), from 2005 to December 2012. Dr. Bailey served as the Managing Director andco-Head of Life Sciences at MDB Capital Group LLC from May 2004 to January 2007. Previously he served as Life Sciences Analyst at Participating Capital, Corp. He has served on the board of directors of multiple public companies. Dr. Bailey has Medical Doctorate from the University of Western Ontario and practiced medicine as an emergency physician for ten years.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co